Lobbying client

WOODWARD PHARMA SERVICES LLC

Company that manufactures, packages, and commercializes diverse pharmaceutical products

Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$30,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2023 to 2025

Filings

9 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination (No Activity)
2nd Quarter 2025
ARENTFOX SCHIFF LLP — reported
1st Quarter - Report (No Activity)
1st Quarter 2025
ARENTFOX SCHIFF LLP — reported
4th Quarter - Report (No Activity)
4th Quarter 2024
ARENTFOX SCHIFF LLP — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2024
ARENTFOX SCHIFF LLP — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2024
ARENTFOX SCHIFF LLP — reported
1st Quarter - Report (No Activity)
1st Quarter 2024
ARENTFOX SCHIFF LLP — reported
4th Quarter - Report
4th Quarter 2023
ARENTFOX SCHIFF LLP $20,000 reported
3rd Quarter - Report
3rd Quarter 2023
ARENTFOX SCHIFF LLP $10,000 reported
Registration
3rd Quarter 2023
ARENTFOX SCHIFF LLP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ARENTFOX SCHIFF LLP 8 $30,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 3

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.